Gwen A Melincoff
CIK 1614890 · last filed 2026-07-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.92M
Companies
7
Total Filings
32
Lifetime Open-Market Net
$15.4K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GANX | Director | — | $1.73 | — | $0 | 5 | 2026-07-17 |
| PLX | Director | 7,500 | $2.33 | $17.5K | $0 | 4 | 2025-09-04 |
| COLL | Director | 52,468 | $35.90 | $1.88M | $0 | 5 | 2024-05-16 |
| SOLENO THERAPEUTICS INC (SLNO) Delisted | Director | 666 | $53.01 | $35.3K | $15.4K | 7 | 2023-05-26 |
| SOLENO THERAPEUTICS INC (SLNOW) Delisted | Director | — | — | — | $0 | 2 | 2019-06-12 |
| ESPR | Director | 6,960 | $3.18 | $22.1K | $0 | 3 | 2019-04-29 |
| Tobira Therapeutics, Inc. (TBRA) Delisted | Director | — | — | — | $0 | 3 | 2016-01-14 |
Recent Filings · Page 3 of 4
32 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-05-20 | SOLENO THERAPEUTICS INC (SLNO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-01-22 | PLX | Grant (A) | — | $0 | EDGAR |
| 2019-11-20 | SOLENO THERAPEUTICS INC (SLNO) Delisted | Buy (P) | +10,000 | $15.4K | EDGAR |
| 2019-06-12 | SOLENO THERAPEUTICS INC (SLNOW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-04-29 | SOLENO THERAPEUTICS INC (SLNOW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-04-29 | ESPR | Grant (A) | +4,707 | $0 | EDGAR |
| 2018-05-29 | ESPR | Grant (A) | +2,253 | $0 | EDGAR |
| 2017-08-11 | ESPR | Grant (A) | — | $0 | EDGAR |
| 2016-11-03 | — | Disp (D) | — | $0 | |
| 2016-01-14 | Tobira Therapeutics, Inc. (TBRA) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.